32 related articles for article (PubMed ID: 38498238)
1. Molecular analysis of therapy resistance in gastric cancer.
Lage H
Dig Dis; 2003; 21(4):326-38. PubMed ID: 14752223
[TBL] [Abstract][Full Text] [Related]
2. Study of therapy resistance in cancer cells with functional proteome analysis.
Poland J; Schadendorf D; Lage H; Schnölzer M; Celis JE; Sinha P
Clin Chem Lab Med; 2002 Mar; 40(3):221-34. PubMed ID: 12005211
[TBL] [Abstract][Full Text] [Related]
3. Valproate modulates the activity of multidrug resistance efflux pumps, as a chemoresistance factor in gastric cancer cells.
Hosseini SA; Mirzaei SA; Kermani S; Yaghoobi H
Mol Biol Rep; 2024 Mar; 51(1):427. PubMed ID: 38498238
[TBL] [Abstract][Full Text] [Related]
4. Crocin Increases Gastric Cancer Cells' Sensitivity to Doxorubicin.
Shariat Razavi SM; Mahmoudzadeh Vaziri R; Karimi G; Arabzadeh S; Keyvani V; Behravan J; Kalalinia F
Asian Pac J Cancer Prev; 2020 Jul; 21(7):1959-1967. PubMed ID: 32711421
[TBL] [Abstract][Full Text] [Related]
5. Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death induction.
Reis MA; Ahmed OB; Spengler G; Molnár J; Lage H; Ferreira MJ
Phytomedicine; 2016 Aug; 23(9):968-78. PubMed ID: 27387405
[TBL] [Abstract][Full Text] [Related]
6. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cytotoxicity of mitoxantrone and daunorubicin by candidone, tephrosin, and bavachinin.
Darzi S; Mirzaei SA; Elahian F; Peymani A; Rahmani B; Pishkhan Dibazar S; Shirian S; Shakeri Chaleshtori L; Aali E
Mol Biol Rep; 2021 Nov; 48(11):7105-7111. PubMed ID: 34564803
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells.
Jahani M; Khanahmad H; Nikpour P
J Gastrointest Cancer; 2021 Jun; 52(2):676-681. PubMed ID: 32621111
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer.
Sun J; Piao J; Li N; Yang Y; Kim KY; Lin Z
FEBS J; 2020 May; 287(10):2118-2133. PubMed ID: 31692265
[TBL] [Abstract][Full Text] [Related]
11. Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells.
Sajadpoor Z; Amini-Farsani Z; Teimori H; Shamsara M; Sangtarash MH; Ghasemi-Dehkordi P; Yadollahi F
Appl Biochem Biotechnol; 2018 Aug; 185(4):1132-1144. PubMed ID: 29468525
[TBL] [Abstract][Full Text] [Related]
12. The role of p53 in cancer drug resistance and targeted chemotherapy.
Hientz K; Mohr A; Bhakta-Guha D; Efferth T
Oncotarget; 2017 Jan; 8(5):8921-8946. PubMed ID: 27888811
[TBL] [Abstract][Full Text] [Related]
13. The anticancer agent prodigiosin is not a multidrug resistance protein substrate.
Elahian F; Moghimi B; Dinmohammadi F; Ghamghami M; Hamidi M; Mirzaei SA
DNA Cell Biol; 2013 Mar; 32(3):90-7. PubMed ID: 23373476
[TBL] [Abstract][Full Text] [Related]
14. Role of ABC transporters in cancer chemotherapy.
Sun YL; Patel A; Kumar P; Chen ZS
Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response.
Cazzalini O; Scovassi AI; Savio M; Stivala LA; Prosperi E
Mutat Res; 2010; 704(1-3):12-20. PubMed ID: 20096807
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
